Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Clinical trial NCT03024437 · TERMINATED
Trial details
- NCT number
- NCT03024437
- Sponsor
- Roberto Pili
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-29
- Primary completion
- 2024-06-24
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.